Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$510M |
| 2 |
Pfizer
PFE
|
+$265M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
Comcast
CMCSA
|
+$191M |
| 5 |
Meta Platforms (Facebook)
META
|
+$184M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$369M |
| 2 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$330M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$230M |
| 4 |
Amgen
AMGN
|
+$223M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.46% |
| 2 | Healthcare | 12.72% |
| 3 | Financials | 10.51% |
| 4 | Industrials | 9.69% |
| 5 | Consumer Staples | 9.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GLDC
2976
DELISTED
GOLDEN ENTERPRISES
GLDC
| $214K | ﹤0.01% |
44,300
+3,800
| +9% | +$16.9K |
|
2977
Pixelworks
PXLW
$37.2M
| $213K | ﹤0.01% |
+7,458
| New | +$265K |
|
2978
Vericel Corp
VCEL
$2.38B
| $212K | ﹤0.01% |
82,157
+48,557
| +145% | +$109K |
|
|
PULB
2979
DELISTED
PULASKI FINANCIAL CORP
PULB
| $212K | ﹤0.01% |
13,300
-3,865
| -23% | -$60.4K |
|
2980
Prosperity Bancshares
PB
$8.9B
| $210K | ﹤0.01% |
4,381
-149,710
| -97% | -$7.69M |
|
|
HBP
2981
DELISTED
Huttig Building Products, Inc.
HBP
| $210K | ﹤0.01% |
55,300
+23,400
| +73% | +$81.9K |
|
|
OCIP
2982
DELISTED
OCI Partners LP
OCIP
| $210K | ﹤0.01% |
+29,508
| New | +$250K |
|
2983
Shopify
SHOP
$168B
| $209K | ﹤0.01% |
81,000
-164,000
| -67% | -$483K |
|
2984
FNB Corp
FNB
$6.76B
| $207K | ﹤0.01% |
15,500
-74,400
| -83% | -$1.02M |
|
|
SMTX
2985
DELISTED
SMTC Corporation
SMTX
| $207K | ﹤0.01% |
133,700
+10,100
| +8% | +$15.1K |
|
2986
Workiva
WK
$3.45B
| $206K | ﹤0.01% |
+11,700
| New | +$202K |
|
2987
Perma-Fix Environmental Services
PESI
$337M
| $205K | ﹤0.01% |
55,200
+9,617
| +21% | +$38.6K |
|
|
ECYT
2988
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $205K | ﹤0.01% |
51,161
-21,538
| -30% | -$99.2K |
|
2989
OneMain Financial
OMF
$7.27B
| $204K | ﹤0.01% |
+4,900
| New | +$225K |
|
|
RELV
2990
DELISTED
Reliv International Inc
RELV
| $204K | ﹤0.01% |
50,143
+229
| +0.5% | +$1.02K |
|
|
SOFO
2991
DELISTED
Sonic Foundry, Inc. Common Stock
SOFO
| $202K | ﹤0.01% |
38,419
+2,000
| +5% | +$13.4K |
|
|
BDRX
2992
Biodexa Pharmaceuticals
BDRX
$131
| – | – |
0
| – | – |
|
2993
Travelers Companies
TRV
$81.1B
| $200K | ﹤0.01% |
+1,776
| New | +$197K |
|
|
PFBX
2994
DELISTED
Peoples Financial Corp/MS
PFBX
| $200K | ﹤0.01% |
22,200
+400
| +2% | +$3.74K |
|
|
PTE
2995
DELISTED
PolarityTE, Inc. Common Stock
PTE
| $198K | ﹤0.01% |
1,270
+20
| +2% | +$3.62K |
|
2996
Willamette Valley Vineyards
WVVI
$12.7M
| $197K | ﹤0.01% |
27,800
+2,900
| +12% | +$21K |
|
|
CNCO
2997
DELISTED
Cencosud S.A.
CNCO
| $197K | ﹤0.01% |
31,800
+21,800
| +218% | +$138K |
|
2998
Compass Diversified
CODI
$752M
| $196K | ﹤0.01% |
+12,331
| New | +$199K |
|
2999
Universal Logistics Holdings
ULH
$388M
| $195K | ﹤0.01% |
+13,900
| New | +$213K |
|
|
AAMI
3000
Acadian Asset Management
AAMI
$2.88B
| $195K | ﹤0.01% |
+12,700
| New | +$196K |
|
Similar funds
Renaissance Technologies's Q4 2015 Portfolio in Review
As of Q4 2015, Renaissance Technologies held 3,639 positions worth $45.9B, up 9.5% from $41.9B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Renaissance Technologies deployed $3.07B of net new capital in Q4 2015, opening 509 new positions and adding to 1,872 existing holdings. Its largest new stake was Apple: 17,852,932 shares worth $470M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $369M trimmed.
- Renaissance Technologies's largest Q4 2015 buy was Apple: 17,852,932 shares worth $470M.
- Renaissance Technologies added most to Gilead Sciences in Q4 2015, an estimated $212M increase.
- Renaissance Technologies's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $369M.
- Renaissance Technologies fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $330M.
- Renaissance Technologies's ten largest holdings make up 9.3% of its $45.9B portfolio in Q4 2015.
- Renaissance Technologies opened 509 new positions and closed 386 in Q4 2015.
- Renaissance Technologies's portfolio value rose 9.5% quarter-over-quarter to $45.9B.
Based on Renaissance Technologies's 13F filing for Q4 2015, filed 11 Feb 2016.